Fresenius Medical Care AG KGaA Debt to Equity Ratio 2010-2025 | FMS
Current and historical debt to equity ratio values for Fresenius Medical Care AG KGaA (FMS) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Fresenius Medical Care AG KGaA debt/equity for the three months ending March 31, 2025 was 0.40.
| Fresenius Medical Care AG KGaA Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $18.15B | $16.33B | 1.11 |
| 2024-12-31 | $19.26B | $17.06B | 1.13 |
| 2024-09-30 | $19.49B | $16.26B | 1.20 |
| 2024-06-30 | $20.15B | $16.36B | 1.23 |
| 2024-03-31 | $20.85B | $16.43B | 1.27 |
| 2023-12-31 | $20.68B | $16.05B | 1.29 |
| 2023-09-30 | $21.99B | $16.80B | 1.31 |
| 2023-06-30 | $21.84B | $16.28B | 1.34 |
| 2023-03-31 | $21.76B | $16.35B | 1.33 |
| 2022-12-31 | $21.39B | $16.28B | 1.31 |
| 2022-09-30 | $21.83B | $16.86B | 1.30 |
| 2022-06-30 | $21.94B | $16.44B | 1.33 |
| 2022-03-31 | $22.65B | $16.32B | 1.39 |
| 2021-12-31 | $24.12B | $16.54B | 1.46 |
| 2021-09-30 | $24.04B | $15.86B | 1.52 |
| 2021-06-30 | $24.31B | $15.44B | 1.58 |
| 2021-03-31 | $24.06B | $15.91B | 1.51 |
| 2020-12-31 | $22.11B | $14.09B | 1.57 |
| 2020-09-30 | $23.84B | $14.80B | 1.61 |
| 2020-06-30 | $22.98B | $14.67B | 1.57 |
| 2020-03-31 | $22.95B | $14.64B | 1.57 |
| 2019-12-31 | $22.07B | $14.82B | 1.49 |
| 2019-09-30 | $21.82B | $15.06B | 1.45 |
| 2019-06-30 | $21.53B | $14.39B | 1.50 |
| 2019-03-31 | $21.72B | $15.02B | 1.45 |
| 2018-12-31 | $15.76B | $15.24B | 1.03 |
| 2018-09-30 | $15.40B | $14.36B | 1.07 |
| 2018-06-30 | $15.58B | $14.29B | 1.09 |
| 2018-03-31 | $16.28B | $13.41B | 1.21 |
| 2017-12-31 | $14.92B | $12.24B | 1.22 |
| 2017-09-30 | $15.96B | $12.54B | 1.27 |
| 2017-06-30 | $15.43B | $11.76B | 1.31 |
| 2017-03-31 | $15.43B | $12.04B | 1.28 |
| 2016-12-31 | $15.48B | $11.46B | 1.35 |
| 2016-09-30 | $15.42B | $11.24B | 1.37 |
| 2016-06-30 | $15.72B | $10.83B | 1.45 |
| 2016-03-31 | $15.26B | $10.81B | 1.41 |
| 2015-12-31 | $14.87B | $10.50B | 1.42 |
| 2015-09-30 | $15.17B | $10.24B | 1.48 |
| 2015-06-30 | $14.98B | $10.43B | 1.44 |
| 2015-03-31 | $14.73B | $10.38B | 1.42 |
| 2014-12-31 | $15.35B | $10.03B | 1.53 |
| 2014-09-30 | $13.73B | $10.52B | 1.31 |
| 2014-06-30 | $13.82B | $10.32B | 1.34 |
| 2014-03-31 | $13.11B | $10.31B | 1.27 |
| 2013-12-31 | $12.99B | $10.13B | 1.28 |
| 2013-09-30 | $12.80B | $9.74B | 1.31 |
| 2013-06-30 | $12.68B | $9.65B | 1.31 |
| 2013-03-31 | $12.24B | $9.90B | 1.24 |
| 2012-12-31 | $12.60B | $9.73B | 1.29 |
| 2012-09-30 | $12.42B | $9.44B | 1.32 |
| 2012-06-30 | $12.73B | $9.01B | 1.41 |
| 2012-03-31 | $12.85B | $9.14B | 1.41 |
| 2011-12-31 | $11.06B | $8.47B | 1.31 |
| 2011-09-30 | $10.41B | $8.22B | 1.27 |
| 2011-06-30 | $10.83B | $8.23B | 1.32 |
| 2011-03-31 | $10.24B | $7.88B | 1.30 |
| 2010-12-31 | $9.29B | $7.80B | 1.19 |
| 2010-09-30 | $9.23B | $7.47B | 1.24 |
| 2010-06-30 | $9.07B | $6.93B | 1.31 |
| 2010-03-31 | $8.75B | $7.13B | 1.23 |
| 2009-12-31 | $8.79B | $7.03B | 1.25 |
| 2009-09-30 | $8.98B | $6.71B | 1.34 |
| 2009-06-30 | $8.95B | $6.39B | 1.40 |
| 2009-03-31 | $8.63B | $6.24B | 1.38 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.000B | $20.627B |
| Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products.. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $192.886B | 84.48 |
| Thermo Fisher Scientific (TMO) | United States | $155.067B | 18.76 |
| Alcon (ALC) | Switzerland | $47.292B | 31.44 |
| Edwards Lifesciences (EW) | United States | $43.778B | 28.70 |
| IDEXX Laboratories (IDXX) | United States | $39.405B | 45.28 |
| DexCom (DXCM) | United States | $33.462B | 51.72 |
| IQVIA Holdings (IQV) | United States | $26.519B | 14.85 |
| Mettler-Toledo (MTD) | United States | $22.895B | 27.23 |
| STERIS (STE) | Ireland | $22.191B | 25.38 |
| Waters (WAT) | United States | $20.881B | 29.46 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.183B | 0.00 |
| Hologic (HOLX) | United States | $12.519B | 13.60 |
| Sysmex ADR (SSMXY) | Japan | $11.422B | 0.00 |
| Penumbra (PEN) | United States | $11.181B | 87.76 |
| Globus Medical (GMED) | United States | $9.966B | 23.37 |
| Masimo (MASI) | United States | $8.327B | 30.72 |
| Teleflex (TFX) | United States | $5.576B | 9.20 |
| Glaukos (GKOS) | United States | $5.174B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.170B | 21.85 |
| TransMedics (TMDX) | United States | $3.152B | 68.53 |
| PROCEPT BioRobotics (PRCT) | United States | $3.033B | 0.00 |
| Veracyte (VCYT) | United States | $2.444B | 34.30 |
| LivaNova (LIVN) | United Kingdom | $2.403B | 14.31 |
| Nihon Kohden (NHNKY) | Japan | $1.935B | 10.58 |
| Elekta AB (EKTAY) | Sweden | $1.893B | 17.01 |
| Alphatec Holdings (ATEC) | United States | $1.862B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.515B | 0.00 |
| Artivion (AORT) | United States | $1.218B | 114.12 |
| Pulse Biosciences (PLSE) | United States | $1.134B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.002B | 5.33 |
| OPKO Health (OPK) | United States | $0.999B | 0.00 |
| SiBone (SIBN) | United States | $0.781B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.682B | 14.91 |
| IRadimed (IRMD) | United States | $0.670B | 33.98 |
| Beta Bionics (BBNX) | United States | $0.646B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.582B | 9.05 |
| AxoGen (AXGN) | United States | $0.573B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.561B | 0.00 |
| RxSight (RXST) | United States | $0.538B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.480B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.480B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.474B | 0.00 |
| NeuroPace (NPCE) | United States | $0.411B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.399B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.377B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.360B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.338B | 7.18 |
| Neuronetics (STIM) | United States | $0.306B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.226B | 13.70 |
| 908 Devices (MASS) | United States | $0.207B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.206B | 0.00 |
| CVRx (CVRX) | United States | $0.203B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.177B | 0.00 |
| Inogen (INGN) | United States | $0.171B | 0.00 |
| LENSAR (LNSR) | United States | $0.163B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.158B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.157B | 0.00 |
| Accuray (ARAY) | United States | $0.153B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.152B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.125B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.106B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.082B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 11.18 |
| EnVVeno Medical (NVNO) | United States | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.055B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.052B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 15.42 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.030B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |